{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:45:31Z","timestamp":1782953131490,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Victorian Comprehensive Cancer Centre Alliance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16052-9","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:05:22Z","timestamp":1778245522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experiences accessing and receiving tumour genetic profiling in Victoria: a consumer-led cross-sectional survey study"],"prefix":"10.1186","volume":"26","author":[{"name":"Victorian Comprehensive Cancer Centre (VCCC) Alliance Personalised Cancer Care Consumer Reference Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Minas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Ilievska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"Nekkalapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Ashley","family":"Granek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Doggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Victorian Comprehensive Cancer Centre (VCCC) Alliance staff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Dall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M","family":"Britto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonie","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Buzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Research Support Team (University of Melbourne)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stratulate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille E","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"16052_CR1","unstructured":"National Cancer Institute. Biomarker Testing for Cancer Treatment. 2021. Available from: https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/biomarker-testing-cancer-treatment. Updated December 14 2021."},{"issue":"9","key":"16052_CR2","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1093\/annonc\/mdv276","volume":"26","author":"C Zhou","year":"2015","unstructured":"Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C, et al. Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802). Ann Oncol. 2015;26(9):1877\u201383.","journal-title":"Ann Oncol"},{"issue":"9","key":"16052_CR3","doi-asserted-by":"publisher","first-page":"a036269","DOI":"10.1101\/cshperspect.a036269","volume":"9","author":"ER Mardis","year":"2019","unstructured":"Mardis ER. The impact of next-generation sequencing on cancer genomics: from discovery to clinic. Cold Spring Harb Perspect Med. 2019;9(9):a036269.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"16052_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41591-022-01717-2","volume":"28","author":"J Mateo","year":"2022","unstructured":"Mateo J, Steuten L, Aftimos P, Andr\u00e9 F, Davies M, Garralda E, et al. Delivering precision oncology to patients with cancer. Nat Med. 2022;28(4):658\u201365.","journal-title":"Nat Med"},{"issue":"6","key":"16052_CR5","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.pec.2020.12.024","volume":"104","author":"M Smith-Uffen","year":"2021","unstructured":"Smith-Uffen M, Bartley N, Davies G, Best M. Motivations and barriers to pursue cancer genomic testing: a systematic review. Patient Educ Couns. 2021;104(6):1325\u201334.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"16052_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-019-0188-1","volume":"17","author":"L Rand","year":"2019","unstructured":"Rand L, Dunn M, Slade I, Upadhyaya S, Sheehan M. Understanding and using patient experiences as evidence in healthcare priority setting. Cost Eff Resour Alloc. 2019;17(1):20.","journal-title":"Cost Eff Resour Alloc"},{"issue":"5","key":"16052_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000353518","volume":"16","author":"JT DeFrank","year":"2013","unstructured":"DeFrank JT, Salz T, Reeder-Hayes K, Brewer NT. Who gets genomic testing for breast cancer recurrence risk? Public Health Genomics. 2013;16(5):215\u201322.","journal-title":"Public Health Genomics"},{"issue":"5","key":"16052_CR8","first-page":"1613","volume":"27","author":"JR Covvey","year":"2019","unstructured":"Covvey JR, Kamal KM, Gorse EE, Mehta Z, Dhumal T, Heidari E, et al. Barriers and facilitators to shared decision-making in oncology: a systematic review of the literature. Support Care Cancer. 2019;27(5):1613\u201337.","journal-title":"Support Care Cancer"},{"issue":"2","key":"16052_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12687-016-0260-x","volume":"7","author":"CME Halverson","year":"2016","unstructured":"Halverson CME, Clift KE, McCormick JB. Was it worth it? Patients\u2019 perspectives on the perceived value of genomic-based individualized medicine. J Community Genet. 2016;7(2):145\u201352.","journal-title":"J Community Genet"},{"issue":"7","key":"16052_CR10","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.pec.2022.01.011","volume":"105","author":"PN Butow","year":"2022","unstructured":"Butow PN, Best MC, Davies G, Schlub T, Napier CE, Bartley N, et al. Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients. Patient Educ Couns. 2022;105(7):2206\u201316.","journal-title":"Patient Educ Couns"},{"issue":"12","key":"16052_CR11","first-page":"3399","volume":"23","author":"PM Carrera","year":"2015","unstructured":"Carrera PM, Olver I. The financial hazard of personalized medicine and supportive care. Support Care Cancer. 2015;23(12):3399\u2013401.","journal-title":"Support Care Cancer"},{"issue":"21","key":"16052_CR12","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.18632\/oncotarget.28076","volume":"12","author":"S Thavaneswaran","year":"2021","unstructured":"Thavaneswaran S, Ballinger M, Butow P, Meiser B, Goldstein D, Lin F, et al. The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey. Oncotarget. 2021;12(21):2169\u201376.","journal-title":"Oncotarget"},{"key":"16052_CR13","unstructured":"National Health and Medical Research Council. Statement on consumer and community involvement in health and medical research. 2024 Available from: https:\/\/www.nhmrc.gov.au\/about-us\/publications\/statement-consumer-and-community-involvement-health-and-medical-research."},{"issue":"11","key":"16052_CR14","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/pon.6045","volume":"31","author":"A Bedaso","year":"2022","unstructured":"Bedaso A, Dejenu G, Duko B. Depression among caregivers of cancer patients: updated systematic review and meta-analysis. Psychooncology. 2022;31(11):1809\u201320.","journal-title":"Psychooncology"},{"key":"16052_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2023.1059605","volume":"14","author":"Z KarimiMoghaddam","year":"2023","unstructured":"KarimiMoghaddam Z, Rostami M, Zeraatchi A, MohammadiBytamar J, Saed O, Zenozian S. Caregiving burden, depression, and anxiety among family caregivers of patients with cancer: an investigation of patient and caregiver factors. Front Psychol. 2023;14:1059605.","journal-title":"Front Psychol"},{"issue":"8","key":"16052_CR16","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.3390\/curroncol31080337","volume":"31","author":"G Dall","year":"2024","unstructured":"Dall G, Harris K, Chan N, Luen SJ, Frentzas S, Day D, et al. Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit. Curr Oncol. 2024;31(8):4519\u201330.","journal-title":"Curr Oncol"},{"issue":"1","key":"16052_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40246-017-0127-1","volume":"11","author":"Y Bylstra","year":"2017","unstructured":"Bylstra Y, Lysaght T, Thrivikraman J, Watson S, Tan P. Ethical frameworks for obtaining informed consent in tumour profiling: an evidence-based case for Singapore. Hum Genomics. 2017;11(1):31.","journal-title":"Hum Genomics"},{"issue":"11","key":"16052_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5694\/mja2.51777","volume":"217","author":"R O\u2019Shea","year":"2022","unstructured":"O\u2019Shea R, Ma AS, Jamieson RV, Rankin NM. Precision medicine in Australia: now is the time to get it right. Med J Aust. 2022;217(11):559\u201363.","journal-title":"Med J Aust"},{"issue":"1","key":"16052_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.breast.2012.04.003","volume":"22","author":"N Ngoi","year":"2013","unstructured":"Ngoi N, Lee SC, Hartman M, Khin LW, Wong A. Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients. Breast. 2013;22(1):47\u201352.","journal-title":"Breast"},{"issue":"1","key":"16052_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41431-018-0257-5","volume":"27","author":"T Yanes","year":"2019","unstructured":"Yanes T, Willis AM, Meiser B, Tucker KM, Best M. Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review. Eur J Hum Genet. 2019;27(1):28\u201335.","journal-title":"Eur J Hum Genet"},{"key":"16052_CR21","volume-title":"National Framework for Consumer Involvement in Cancer Control","author":"Cancer Australia","year":"2011","unstructured":"Cancer Australia, Cancer Voices Australia. National Framework for Consumer Involvement in Cancer Control. Canberra, ACT: Cancer Australia; 2011."},{"issue":"1","key":"16052_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40900-017-0062-2","volume":"3","author":"S Staniszewska","year":"2017","unstructured":"Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. Research Involvement and Engagement. 2017;3(1):13.","journal-title":"Research Involvement and Engagement"},{"issue":"1","key":"16052_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12961-018-0293-1","volume":"16","author":"G Moore","year":"2018","unstructured":"Moore G, Redman S, Rudge S, Haynes A. Do policy-makers find commissioned rapid reviews useful? Health Res Policy Syst. 2018;16(1):17.","journal-title":"Health Res Policy Syst"},{"issue":"1","key":"16052_CR24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1186\/s12885-019-5920-x","volume":"19","author":"MC Best","year":"2019","unstructured":"Best MC, Bartley N, Jacobs C, Juraskova I, Goldstein D, Newson AJ, et al. Patient perspectives on molecular tumor profiling: \u201cWhy wouldn\u2019t you?\u201d BMC Cancer. 2019;19(1):753.","journal-title":"BMC Cancer"},{"issue":"19","key":"16052_CR25","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1002\/cncr.28807","volume":"120","author":"PS Blanchette","year":"2014","unstructured":"Blanchette PS, Spreafico A, Miller FA, Chan K, Bytautas J, Kang S, et al. Genomic testing in cancer: Patient knowledge, attitudes, and expectations. Cancer. 2014;120(19):3066\u201373.","journal-title":"Cancer"},{"key":"16052_CR26","unstructured":"McKercher KA. Beyond Sticky Notes: Co-design for Real : Mindsets, Methods and Movements: Beyond Sticky Notes. 2020."},{"issue":"1","key":"16052_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0253-7184.69003","volume":"31","author":"S Aslam","year":"2010","unstructured":"Aslam S, Emmanuel P. Formulating a researchable question: A critical step for facilitating good clinical research. Indian J Sex Transm Dis AIDS. 2010;31(1):47\u201350.","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"16052_CR28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1590\/S0104-11692007000300023","volume":"15","author":"CM Santos","year":"2007","unstructured":"Santos CM, Pimenta C, Nobre MRC. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem. 2007;15:508\u201311.","journal-title":"Rev Lat Am Enfermagem"},{"key":"16052_CR29","doi-asserted-by":"crossref","unstructured":"Mohanan S, Parameswaran N. FINER criteria \u2013 What does it mean? CosmoDerma. 2022;2:115. https:\/\/cosmoderma.org\/finer-criteria-what-does-it-mean\/.","DOI":"10.25259\/CSDM_123_2022"},{"key":"16052_CR30","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"16052_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"5","key":"16052_CR32","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41431-018-0325-x","volume":"27","author":"J Savard","year":"2019","unstructured":"Savard J, Hickerton C, Tytherleigh R, Terrill B, Turbitt E, Newson AJ, et al. Australians\u2019 views and experience of personal genomic testing: survey findings from the Genioz study. Eur J Hum Genet. 2019;27(5):711\u201320.","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"16052_CR33","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/cncr.24990","volume":"116","author":"JP Tzeng","year":"2010","unstructured":"Tzeng JP, Mayer D, Richman AR, Lipkus I, Han PK, Valle CG, et al. Women\u2019s experiences with genomic testing for breast cancer recurrence risk. Cancer. 2010;116(8):1992\u20132000.","journal-title":"Cancer"},{"issue":"2","key":"16052_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/0272989X20977878","volume":"41","author":"KD Valentine","year":"2021","unstructured":"Valentine KD, Vo H, Fowler FJ Jr, Brodney S, Barry MJ, Sepucha KR. Development and evaluation of the shared decision making process scale: a short patient-reported measure. Med Decis Making. 2021;41(2):108\u201319.","journal-title":"Med Decis Making"},{"issue":"2","key":"16052_CR35","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/cam4.5047","volume":"12","author":"K Ahmed","year":"2023","unstructured":"Ahmed K, Siegel JJ, Morgan-Linnell SK, LiPira K. Attitudes of patients with cutaneous melanoma toward prognostic testing using the 31-gene expression profile test. Cancer Med. 2023;12(2):2008\u201315.","journal-title":"Cancer Med"},{"issue":"4","key":"16052_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X03256005","volume":"23","author":"JC Brehaut","year":"2003","unstructured":"Brehaut JC, O\u2019Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, et al. Validation of a decision regret scale. Med Decis Making. 2003;23(4):281\u201392.","journal-title":"Med Decis Making"},{"issue":"1","key":"16052_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12885-018-4310-0","volume":"18","author":"M Best","year":"2018","unstructured":"Best M, Newson AJ, Meiser B, Juraskova I, Goldstein D, Tucker K, et al. The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling. BMC Cancer. 2018;18(1):389.","journal-title":"BMC Cancer"},{"key":"16052_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0959-8049(01)00448-8","volume":"38","author":"P Fayers","year":"2002","unstructured":"Fayers P, Bottomley A. Quality of life research within the EORTC\u2014the EORTC QLQ-C30. Eur J Cancer. 2002;38:125\u201333.","journal-title":"Eur J Cancer"},{"key":"16052_CR39","unstructured":"Victorian Government. demography map. 2024. Available from: https:\/\/mapshare.vic.gov.au\/demography-map\/."},{"issue":"9","key":"16052_CR40","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S1470-2045(16)30147-4","volume":"17","author":"ML Ballinger","year":"2016","unstructured":"Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, et al. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol. 2016;17(9):1261\u201371.","journal-title":"Lancet Oncol"},{"issue":"6","key":"16052_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104516","volume":"65","author":"B Meiser","year":"2022","unstructured":"Meiser B, Butow P, Davies G, Napier CE, Schlub TE, Bartley N, et al. Psychological predictors of cancer patients\u2019 and their relatives\u2019 attitudes towards the return of genomic sequencing results. Eur J Med Genet. 2022;65(6):104516.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"16052_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/pme.14.62","volume":"12","author":"D Patil","year":"2015","unstructured":"Patil D, Issa AM. Factors affecting the adoption and use of gene expression profiling by oncologists in clinical practice. Personal Med. 2015;12(1):33\u201342.","journal-title":"Personal Med"},{"key":"16052_CR43","unstructured":"Australia C. National Framework for Genomics in Cancer Control. 2025."},{"issue":"5","key":"16052_CR44","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s13187-019-01535-0","volume":"35","author":"BA McDaniels","year":"2020","unstructured":"McDaniels BA, Hianik RS, Bellcross C, Shaib WL, Switchenko J, Dixon MD, et al. The Impact of Genetic Counseling Educational Tools on Patients\u2019 Knowledge of Molecular Testing Terminology. J Cancer Educ. 2020;35(5):864\u201370.","journal-title":"J Cancer Educ"},{"issue":"2","key":"16052_CR45","first-page":"94","volume":"7","author":"M Fran","year":"2023","unstructured":"Fran M, Amy N, Elly L, Melissa M, Rigan T, Taryn C, et al. Genomics education for medical specialists: case-based specialty workshops and blended learning. J Transl Gen Genom. 2023;7(2):94\u2013109.","journal-title":"J Transl Gen Genom"},{"key":"16052_CR46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1200\/PO.19.00338","volume":"4","author":"JS de Moor","year":"2020","unstructured":"de Moor JS, Gray SW, Mitchell SA, Klabunde CN, Freedman AN. Oncologist confidence in genomic testing and implications for using multimarker tumor panel tests in practice. JCO Precis Oncol. 2020;4:620\u201331.","journal-title":"JCO Precis Oncol"},{"key":"16052_CR47","unstructured":"Total ban on the use of adverse genetic testing results in life insurance [press release]. Treasury, Australian Government. 2024."},{"key":"16052_CR48","doi-asserted-by":"publisher","unstructured":"Kalra A, Ganesan S, Sia JJY, Papalois KB, Pandya A, Xiong R, Wei X, Oxley SG, Mansour L, Fierheller CT, Deshmukh PA, Mohamed H, Dibden A, Blyuss O, Sideris M, Legood R, Manchanda R. Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025;233(4):276\u201391. https:\/\/doi.org\/10.1016\/j.ajog.2025.04.044.","DOI":"10.1016\/j.ajog.2025.04.044"},{"issue":"2","key":"16052_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1634\/theoncologist.2018-0090","volume":"24","author":"I Henselmans","year":"2019","unstructured":"Henselmans I, van Laarhoven HWM, de Haes H, Tokat M, Engelhardt EG, van Maarschalkerweerd PEA, et al. Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial. Oncologist. 2019;24(2):259\u201365.","journal-title":"Oncologist"},{"issue":"1","key":"16052_CR50","first-page":"92","volume":"3","author":"RM Epstein","year":"2017","unstructured":"Epstein RM, Duberstein PR, Fenton JJ, Fiscella K, Hoerger M, Tancredi DJ, et al. Effect of a Patient-Centered Communication Intervention on Oncologist-Patient Communication, Quality of Life, and Health Care Utilization in Advanced Cancer: The VOICE Randomized Clinical Trial. JAMA Oncol. 2017;3(1):92\u2013100.","journal-title":"JAMA Oncol"},{"key":"16052_CR51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2147\/CEOR.S449711","volume":"16","author":"V Berdunov","year":"2024","unstructured":"Berdunov V, Cuyun Carter G, Laws E, Luo R, Russell CA, Campbell S, et al. Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score(\u00ae) Test from a US Societal Perspective. Clinicoecon Outcomes Res. 2024;16:471\u201382.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"11","key":"16052_CR52","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/14740338.2022.2151584","volume":"21","author":"P Di Nardo","year":"2022","unstructured":"Di Nardo P, Lisanti C, Garutti M, Buriolla S, Alberti M, Mazzeo R, et al. Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects. Expert Opin Drug Saf. 2022;21(11):1341\u201355.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"16052_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/ajco.14033","volume":"20","author":"AL Young","year":"2024","unstructured":"Young AL, Ip E, Scheinberg T, Harrison M, Beale P, Goodwin A. An Australian mainstream genetic testing program: Clinicians views about current and future practices. Asia Pac J Clin Oncol. 2024;20(1):119\u201327.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"6","key":"16052_CR54","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S1470-2045(23)00182-1","volume":"24","author":"SA McIntosh","year":"2023","unstructured":"McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments. Lancet Oncol. 2023;24(6):636\u201345.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16052-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:04:40Z","timestamp":1782950680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16052-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16052"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16052-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6508330\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the University of Melbourne Human Ethics Committee (#27758). All participants provided written informed consent online via REDCap and have been informed that no identifying details will be published in this manuscript. Our study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"799"}}